• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    Abry Partners and BHMS Announce Sale of Innovisk to Ryan Specialty

    11/4/24 4:02:00 PM ET
    $RYAN
    Specialty Insurers
    Finance
    Get the next $RYAN alert in real time by email

    BOSTON and WESTPORT, Conn., Nov. 4, 2024 /PRNewswire/ -- Abry Partners, a Boston-based private equity firm, and BHMS Investments, LP, a Connecticut-based private equity firm, have completed the sale of Innovisk to Ryan Specialty (NYSE:RYAN), a leading international specialty insurance services firm.

    Innovisk was founded in 2017 and consists of a diverse, non-correlated portfolio of seven highly regarded specialty MGUs. Innovisk's lines of business include environmental, transactional liability, U.S. and international financial lines, professional liability for lawyers, commercial auto liability, and UK professional indemnity and P&C. Headquartered in London, Innovisk also has offices in the United States and India.

    Commenting on Innovisk, Tim Turner, CEO of Ryan Specialty, said, "We have tremendous respect for Innovisk. Their outstanding management team has demonstrated a differentiated value proposition to brokers, agents and carriers, and their underwriting talent is among the best in the industry. At Ryan Specialty, we see new product innovation and diversification as essential components of the value that we bring to our clients and trading partners. Innovisk clearly shares this view and has made the critical investments to be able to not only launch new products but bring those products to market quickly."

    David Thomas, CEO of Innovisk, stated, "Ryan Specialty has the right leadership and platform to accelerate the growth of our exceptional business lines while offering significant ongoing opportunities to our employees. With the shared mission to innovate where there is need and service clients and trading partners at the highest level, the addition of our team to RSUM will be smooth and empowering for our teammates. We have watched Ryan Specialty grow and earn the reputation as a specialty insurance leader, and we couldn't be more excited to join this widely respected firm. I would like to thank Abry and BHMS for their collaborative partnership, aligning early on our vision, then offering strategic insights to drive thoughtful execution throughout a three-year journey."

    Today's announcement is evidence of Innovisk's strength and success to date. "The Innovisk team has built a differentiated platform focused on underwriting quality, enhanced by industry-leading data and technology and backed by a world-class panel of insurance carrier partners," said Nathan Ott, Partner at Abry Partners. Innovisk has experienced strong organic growth since Abry and BHMS invested in 2021. With the support of Abry and BHMS' deep insurance domain expertise and robust operating resources, Innovisk expanded its global reach and made significant investments to accelerate growth.

    Vidur Khatri, Principal, Abry Partners, added, "During our partnership with Innovisk, we have seen consistent execution and dramatic growth. In combination with Ryan Specialty, we are confident that Innovisk is poised to achieve its highest ambitions. We wish the Innovisk team continued success."

    Kevin Angelis, Managing Partner at BHMS, added, "We had the privilege of partnering with David Thomas and the exceptional team at Innovisk, immediately aligning with their vision and ambition. Their commitment to delivering a culture of world-class underwriting by leveraging innovative technology has been instrumental in building a winning formula. We're proud to have contributed to Innovisk's development, and this transaction is an excellent step for the company, unlocking new opportunities for the platform."

    Ardea Partners served as financial advisor to Innovisk, with Kirkland & Ellis LLP and Hill Dickinson LLP acting as legal counsel to Abry, BHMS, and Innovisk.

    About Innovisk

    Headquartered in London, UK, Innovisk operates a portfolio of MGA programs across the U.S. and UK. Innovisk's MGA operations span across diversified lines of business, including small commercial P&C, environmental liability, professional indemnity and international rep & warranty insurance. The Company is led by an experienced management team and leverages a centralized and scalable proprietary technology and data platform to optimize underwriting, risk analytics, pricing and distribution. Innovisk is supported by numerous A-rated reinsurers and blue-chip distribution partners across wholesale and retail channels. For more information about Innovisk, visit www.innovisk.com.

    About Abry Partners

    Abry Partners is one of the most experienced and successful sector-focused private equity investment firms in North America. Since its founding in 1989, the firm has completed over $90 billion of leveraged transactions and other private equity or preferred equity placements. Currently, the firm manages over $5.0 billion of capital across its active funds. For more information about Abry Partners, visit www.abry.com.

    About BHMS

    BHMS is a private investment firm focused on the North American middle market. The firm was founded in 2010 and is based in Westport, CT. BHMS invests in a variety of control and structured equity opportunities ranging from consolidation strategies to conventional leveraged buyouts. The firm focuses on industries in which it has deep experience and relationships including business & insurance services. BHMS is currently deploying capital from its most recent fund, which it closed in July 2024. For more information about BHMS, visit bhmsinvestments.com.

    About Ryan Specialty

    Founded in 2010, Ryan Specialty is a service provider of specialty products and solutions for insurance brokers, agents and carriers. Ryan Specialty provides distribution, underwriting, product development, administration and risk management services by acting as a wholesale broker and a managing underwriter with delegated authority from insurance carriers. Ryan Specialty's mission is to provide industry-leading innovative specialty insurance solutions for insurance brokers, agents and carriers. For more information, visit ryanspecialty.com.

    Contact: Chris Tofalli

    Chris Tofalli Public Relations, LLC

    914-834-4334

    Cision View original content:https://www.prnewswire.com/news-releases/abry-partners-and-bhms-announce-sale-of-innovisk-to-ryan-specialty-302295838.html

    SOURCE ABRY Partners

    Get the next $RYAN alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $RYAN

    DatePrice TargetRatingAnalyst
    5/13/2025$81.00Neutral → Buy
    Goldman
    4/10/2025$89.00Buy
    TD Cowen
    12/5/2024$90.00Overweight
    Morgan Stanley
    9/24/2024$65.00 → $75.00Market Perform → Outperform
    BMO Capital Markets
    9/5/2024$76.00Overweight
    Barclays
    7/11/2024$58.00 → $60.00Overweight → Equal Weight
    Wells Fargo
    5/22/2024$67.00Buy
    BofA Securities
    5/6/2024Outperform → Peer Perform
    Wolfe Research
    More analyst ratings

    $RYAN
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Director Kuczinski Anthony J bought $21,111 worth of shares (300 units at $70.37), increasing direct ownership by 18% to 1,992 units (SEC Form 4)

      4 - RYAN SPECIALTY HOLDINGS, INC. (0001849253) (Issuer)

      5/13/25 4:35:19 PM ET
      $RYAN
      Specialty Insurers
      Finance
    • EVP & CHRO Conklin Michael bought 7,637 units of Class A Common Stock and covered exercise/tax liability with 2,902 units of Class A Common Stock (SEC Form 4)

      4 - RYAN SPECIALTY HOLDINGS, INC. (0001849253) (Issuer)

      4/2/25 6:56:35 PM ET
      $RYAN
      Specialty Insurers
      Finance
    • Director Ryan Patrick G Jr bought $5,212 worth of shares (75 units at $69.50), increasing direct ownership by 0.03% to 253,733 units (SEC Form 4)

      4 - RYAN SPECIALTY HOLDINGS, INC. (0001849253) (Issuer)

      3/12/25 4:37:34 PM ET
      $RYAN
      Specialty Insurers
      Finance